The global lateral lumbar interbody fusion market will experience growth through 2024, according to a Transparency Market Research report.
Here are six observations:
1. A minimally invasive procedure, lateral lumbar interbody fusion is designed to yield less blood loss and decrease tissue damage.
2. The procedure's higher visualization and technological advancements in the market will boost adoption, but the procedure's costliness as well as risks will hinder growth.
3. Some procedure risks include psoas muscles and neural network injury as well as bone graft fusion complications.
4. Market vendors are increasingly offering preoperative and postoperative care for patients as well, expanding their offerings.
5. North America leads the space, due to technologically advanced products and research and development investments.
6. DePuy Synthes, NuVasive, Stryker, Smith & Nephew, Medtronic, Paradigm Spine and Alphatec Spine dominate the market.